M. Scott Lucia

26.1k total citations · 6 hit papers
193 papers, 14.4k citations indexed

About

M. Scott Lucia is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, M. Scott Lucia has authored 193 papers receiving a total of 14.4k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pulmonary and Respiratory Medicine, 37 papers in Surgery and 37 papers in Molecular Biology. Recurrent topics in M. Scott Lucia's work include Prostate Cancer Treatment and Research (90 papers), Prostate Cancer Diagnosis and Treatment (84 papers) and Bladder and Urothelial Cancer Treatments (22 papers). M. Scott Lucia is often cited by papers focused on Prostate Cancer Treatment and Research (90 papers), Prostate Cancer Diagnosis and Treatment (84 papers) and Bladder and Urothelial Cancer Treatments (22 papers). M. Scott Lucia collaborates with scholars based in United States, Canada and Türkiye. M. Scott Lucia's co-authors include Ian M. Thompson, Catherine M. Tangen, Phyllis J. Goodman, Charles A. Coltman, Scott M. Lippman, Howard L. Parnes, Leslie G. Ford, Gary J. Miller, Adrie van Bokhoven and Lori M. Minasian and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of the American Chemical Society.

In The Last Decade

M. Scott Lucia

190 papers receiving 14.0k citations

Hit Papers

The Influence of Finasteride on the Development of Prosta... 2003 2026 2010 2018 2003 2004 2009 2006 2006 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Scott Lucia United States 54 7.7k 3.2k 2.2k 2.2k 1.8k 193 14.4k
Kurt Miller Germany 59 9.1k 1.2× 4.6k 1.4× 2.9k 1.3× 2.1k 1.0× 3.5k 1.9× 358 14.7k
Phyllis J. Goodman United States 45 6.8k 0.9× 2.3k 0.7× 3.5k 1.5× 2.0k 0.9× 1.9k 1.0× 160 13.2k
Georg Bartsch Austria 65 4.7k 0.6× 2.9k 0.9× 1.6k 0.7× 3.0k 1.3× 1.2k 0.7× 299 11.9k
Howard L. Parnes United States 46 6.6k 0.9× 2.0k 0.6× 2.3k 1.0× 1.5k 0.7× 1.5k 0.8× 205 10.9k
Seiji Naito Japan 56 3.8k 0.5× 4.4k 1.4× 2.6k 1.1× 2.4k 1.1× 1.8k 1.0× 453 11.3k
David G. McLeod United States 61 9.7k 1.3× 3.0k 0.9× 2.5k 1.1× 1.9k 0.9× 2.4k 1.3× 271 13.3k
Gerald L. Andriole United States 63 10.6k 1.4× 2.7k 0.8× 2.4k 1.1× 3.2k 1.4× 2.0k 1.1× 455 17.3k
Dominique Chopin France 59 5.4k 0.7× 4.7k 1.4× 1.7k 0.7× 5.0k 2.2× 1.3k 0.7× 257 11.6k
Steven Joniau Belgium 59 14.5k 1.9× 3.1k 1.0× 2.9k 1.3× 3.4k 1.5× 2.8k 1.5× 458 18.7k
Laurence Klotz Canada 71 15.7k 2.0× 3.5k 1.1× 3.5k 1.6× 4.3k 1.9× 2.4k 1.3× 480 20.6k

Countries citing papers authored by M. Scott Lucia

Since Specialization
Citations

This map shows the geographic impact of M. Scott Lucia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Scott Lucia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Scott Lucia more than expected).

Fields of papers citing papers by M. Scott Lucia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Scott Lucia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Scott Lucia. The network helps show where M. Scott Lucia may publish in the future.

Co-authorship network of co-authors of M. Scott Lucia

This figure shows the co-authorship network connecting the top 25 collaborators of M. Scott Lucia. A scholar is included among the top collaborators of M. Scott Lucia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Scott Lucia. M. Scott Lucia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Zhaohui, Zhaohui Wang, Yong Wang, et al.. (2024). Toxicology, pharmacokinetics, and immunogenicity studies of CCR4-IL2 bispecific immunotoxin in rats and minipigs. European Journal of Pharmacology. 968. 176408–176408. 1 indexed citations
3.
Armetta, Francesco, et al.. (2024). Chemistry of Street Art: Neural Network for the Spectral Analysis of Berlin Wall Colors. Journal of the American Chemical Society. 146(51). 35321–35328. 4 indexed citations
4.
Black, Peter C., Catherine M. Tangen, Parminder Singh, et al.. (2023). Phase 2 Trial of Atezolizumab in Bacillus Calmette-Guérin–unresponsive High-risk Non–muscle-invasive Bladder Cancer: SWOG S1605. European Urology. 84(6). 536–544. 48 indexed citations
5.
Romero, Lina, et al.. (2022). MIRO2 Regulates Prostate Cancer Cell Growth via GCN1-Dependent Stress Signaling. Molecular Cancer Research. 20(4). 607–621. 11 indexed citations
6.
Schenk, Jeannette M., Cathee Till, Marian L. Neuhouser, et al.. (2022). Differential Biopsy Patterns Influence Associations between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial. Cancer Epidemiology Biomarkers & Prevention. 31(11). 2063–2069. 1 indexed citations
7.
Flaig, Thomas W., Catherine M. Tangen, Siamak Daneshmand, et al.. (2021). A Randomized Phase II Study of Coexpression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Bladder Cancer (SWOG S1314; NCT02177695). Clinical Cancer Research. 27(9). 2435–2441. 58 indexed citations
8.
Hurwitz, Lauren M., İbrahim Kulaç, Berrak Gümüşkaya, et al.. (2020). Use of Aspirin and Statins in Relation to Inflammation in Benign Prostate Tissue in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prevention Research. 13(10). 853–862. 7 indexed citations
9.
Torkko, Kathleen C., Cathee Till, Catherine M. Tangen, et al.. (2020). Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial. Cancer Prevention Research. 13(6). 521–530. 4 indexed citations
10.
Tangen, Catherine M., Jeannette M. Schenk, Cathee Till, et al.. (2019). Variations in prostate biopsy recommendation and acceptance confound evaluation of risk factors for prostate cancer: Examining race and BMI. Cancer Epidemiology. 63. 101619–101619. 4 indexed citations
11.
Dai, James Y., Michael LeBlanc, Phyllis J. Goodman, et al.. (2018). Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride. Cancer Prevention Research. 12(2). 113–120. 2 indexed citations
12.
Nash, Sarah H., Jeannette M. Schenk, Alan R. Kristal, et al.. (2015). Association between Serum Phospholipid Fatty Acids and Intraprostatic Inflammation in the Placebo Arm of the Prostate Cancer Prevention Trial. Cancer Prevention Research. 8(7). 590–596. 8 indexed citations
13.
Nickerson, Michael L., Garrett M. Dancik, Kate M. Im, et al.. (2014). Concurrent Alterations in TERT , KDM6A , and the BRCA Pathway in Bladder Cancer. Clinical Cancer Research. 20(18). 4935–4948. 87 indexed citations
14.
Wright, Margaret E., Steve D. Groshong, Kirsti Husgafvel‐Pursiainen, et al.. (2013). Effects of beta-Carotene Supplementation on Molecular Markers of Lung Carcinogenesis in Male Smokers. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 6 indexed citations
15.
O’Brien, Jenean, Traci R. Lyons, Jenifer Monks, et al.. (2010). Alternatively Activated Macrophages and Collagen Remodeling Characterize the Postpartum Involuting Mammary Gland across Species. American Journal Of Pathology. 176(3). 1241–1255. 224 indexed citations
16.
Troyer, Dean A., M. Scott Lucia, Marcella Baldewijns, et al.. (2009). Prostate Cancer Detected by Methylated Gene Markers in Histopathologically Cancer-Negative Tissues from Men with Subsequent Positive Biopsies. Cancer Epidemiology Biomarkers & Prevention. 18(10). 2717–2722. 38 indexed citations
17.
Lucia, M. Scott, Amy K. Darke, Phyllis J. Goodman, et al.. (2008). Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention. Cancer Prevention Research. 1(3). 167–173. 72 indexed citations
18.
Redman, Mary W., Catherine M. Tangen, Phyllis J. Goodman, et al.. (2008). Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach. Cancer Prevention Research. 1(3). 174–181. 140 indexed citations
19.
Thompson, Ian M., Chi Chen, Donna P. Ankerst, et al.. (2006). Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer. JNCI Journal of the National Cancer Institute. 98(16). 1128–1133. 217 indexed citations
20.
Vodovotz, Yoram, Andrew G. Geiser, Louis Chesler, et al.. (1996). Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse.. The Journal of Experimental Medicine. 183(5). 2337–2342. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026